In liver cancer, tumor-associated neutrophils (TANs) stimulate miR-301b-3p to express, which subsequently inhibits the level of CYLD and LSAMP and upregulates chemokine (CXCL5), leading to a higher infiltration of TANs (Zhou et al., 2019). Here, CYLD is linked to liver cancer.